Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.
作者信息
Waid T H, Lucas B A, Thompson J S, Munch L C, Brown S, Kryscio R, Prebeck R, VanHoy M A, Jezek D
机构信息
Department of Medicine, University of Kentucky, Lexington.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):1062-5.
PMID:1899152
Abstract
摘要
相似文献
1
Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.使用抗T细胞抗原受体复合物αβ（T10B9.1A-31）或抗CD3（OKT3）单克隆抗体治疗急性排斥反应：一项前瞻性随机双盲试验的结果
Transplant Proc. 1991 Feb;23(1 Pt 2):1062-5.
2
T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.T10B9.1A-31抗T细胞单克隆抗体：实体器官移植排斥反应的临床前研究与临床治疗
Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):61-70.
3
Prophylactic use of anti-CD3 monoclonal antibody WT32 in kidney transplantation.
Transplant Proc. 1991 Feb;23(1 Pt 2):1072-3.
4
A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1050-1.
5
Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.肾移植受者中使用T10B9.1A - 31或OKT3治疗急性细胞排斥反应。
Transplantation. 1992 Jan;53(1):80-6. doi: 10.1097/00007890-199201000-00015.
6
OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.
Transplant Proc. 1991 Feb;23(1 Pt 2):1581-2.
7
8
Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.采用T10B9.1A-31进行心脏移植诱导免疫治疗：一项I期研究。
J Heart Lung Transplant. 1997 Sep;16(9):913-6.
9
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.
Transplant Proc. 1991 Feb;23(1 Pt 2):1052-4.
10
The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1039-40.
引用本文的文献
1
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
2
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patients.小鼠IgM抗人αβ T细胞受体抗体TOL101在肾移植患者中的药代动力学和药效学
Clin Pharmacokinet. 2014 Jul;53(7):649-57. doi: 10.1007/s40262-014-0138-1.
3
Current landscape for T-cell targeting in autoimmunity and transplantation.自身免疫和移植中 T 细胞靶向的现状。
Immunotherapy. 2011 Jul;3(7):853-70. doi: 10.2217/imt.11.61.
Zotero 插件